KEVIN MCCARTHY: Open Payments
NPI 1427184308 · ORANGE PARK, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,068 in 79 payments from 14 companies in 2025. Trend: 2023 $515 · 2024 $1,157 · 2025 $2,068
Food & beverage: $2,068
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 8 | $360 |
| Otsuka America Pharmaceutical, Inc. | 5 | $309 |
| Vanda Pharmaceuticals Inc. | 10 | $252 |
| E.R. Squibb & Sons, L.L.C. | 21 | $235 |
| Alkermes, Inc. | 8 | $197 |
| ABBVIE INC. | 8 | $180 |
| Supernus Pharmaceuticals, Inc. | 2 | $143 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $111 |
| Bausch Health US, LLC | 4 | $77 |
| Janssen Pharmaceuticals, Inc | 3 | $60 |
Products named: Auvelity, COBENFY, FANAPT, REXULTI, ARISTADA, VRAYLAR, Qelbree, ABILIFY MAINTENA.
Industry payments across FL — which companies pay providers there.
